Abstract
Prostatitis is a common urologic diagnosis. Although treatment algorithms are available for this poorly understood entity, several adaptations must be made in order to accommodate the therapeutic needs of HIV-positive patients. The most important consideration when treating HIV-infected patients for prostatitis is their current immune status, whether they are immunocompromised or not (non-progressive disease or reconstituted with highly active antiretroviral therapy). A treatment algorithm for those with chronic bacterial prostatitis (Category II), chronic nonbacterial prostatitis (Category IIIA), and prostatodynia (Category IIIB) is presented in this article. In the HIV-positive patient population, there is a greater likelihood for atypical pathogens including fungi, tuberculosis, anaerobes, and viruses. Because the HIV-infected patient is at increased risk for the development of prostatic abscess and urosepsis than the general population, increased monitoring and evaluation and longer-term appropriately directed antimicrobial therapy are required.
Similar content being viewed by others
References and Recommended Reading
Habermacher GM, Chason JT, Schaeffer AJ: Prostatitis/ chronic pelvic pain syndrome. Annu Rev Med 2006, 57:195–206.
Collins MM, Stafford RS, O’Leary MP, Barry MJ: How common is prostatitis? A national survey of physician visits. J Urol 1998, 159:1224–1228.
Nickel JC: Prostatitis and related conditions. In Campbell’s Urology, edn 8. Edited by Walsh PC, Retik AB, Vaughan ED, Wein AJ. Philadelphia: WB Saunders; 2002:603–630.
Bjerklund Johansen TE, Gruneberg RN, Guibert J, et al.: The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol 1998, 34:457–466.
McNaughton Collins M, Fowler FJ Jr, Elliott DB, et al.: Diagnosing and treating chronic prostatitis: Do urologists use the four-glass test? Urology 2000, 55:403–407.
Nickel JC, Downey J, Johnston B, et al.: Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective, multicenter clinical trial. J Urol 2001, 165:1539–1544.
Nickel JC, Downey J, Clark J, et al.: Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized, placebo-controlled, multicenter trial. Urology 2003, 62:614–617.
Alexander RB, Propert KJ, Schaeffer AJ, et al.: Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004, 141:581–589.
Staiman VR, Lowe FC: Urologic problems in patients with acquired immunodeficiency syndrome. Digital Urology Journal: http://www.duj.com/Article/Staiman/Staiman. html. Accessed December 2, 2005. Excellent overview of the general topic.
Staiman VR, Kwan DJ, Lowe FC: HIV and the genitourinary tract. Infect Med 1996, 13:598,601,605–608,638.
Staiman VR, Kwan DJ, Lowe FC: Genitourinary manifestations of AIDS. Infect Urol 1996, 9:73–78,92.
Benson PJ, Smith CS: Cytomegalovirus prostatitis. Urology 1992, 40:165–167.
Kwan DJ, Lowe FC: Genitourinary manifestations of the acquired immunodeficiency syndrome. Urology 1995, 45:13–27.
Hood SV, Bell D, McVey R, et al.: Prostatitis and epididymo-orchitis due to Aspergillus fumigatus in a patient with AIDS. Clin Infect Dis 1998, 26:229–231.
Adams JR Jr, Mata JA, Culkin DJ, et al.: Acquired immunode ficiency syndrome manifesting as prostate nodule secondary to cryptococcal infection. Urology 1992, 39:289–291.
Marans HY, Mandell W, Kislak JW, et al.: Prostatic abscess due to histoplasma capsulatum in the acquired immunode ficiency syndrome. J Urol 1991, 145:1275–1276.
Dikov D, Chatelet FP, Dimitrakov J: Pathologic features of necrotizing adenoviral prostatitis in an AIDS patient. Int J Surg Pathol 2005, 13:227–231.
Trauzzi SJ, Kay CJ, Kaufman DG, Lowe FC: Management of prostatic abscess in patients with human immunodeficiency syndrome. Urology 1994, 43:629–633.
Murphy EL, Collier AC, Kalish LA, et al.: Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001, 135:17–26.
Hyun G, Lowe FC: AIDS and the urologist. Urol Clin North Am 2003, 30:101–109.
Bertschinger K, Trinkler F, Reili I, Kubik-Huch RA: Sonographic and MR findings of an extensive, HIV-related prostatic abscess. J Magn Reson Imaging 1999, 9:488–490.
Oliveira P, Andrade JA, Porto HC, et al.: Diagnosis and treatment of prostatic abscess. Int Braz J Urol 2003, 29:30–34.
Heyns CF, Fisher M: The urological management of the patient with acquired immunodeficiency syndrome. BJU Int 2005, 95:709–716.
Nickel JC, Moon T: Chronic bacterial prostatitis: an evolving clinical enigma. Urology 2005, 66:2–8. Recent review of this problem.
Kay CJ, Trauzzi SJ, Lowe FC: Imaging and management of prostatic abscess associated with the HIV syndrome. Infect Urol 1995, 8:86–90.
Bertschinger K, Trinkler F, Reili I, Kubik-Huch RA: Sonographic and MR findings of an extensive, HIV-related prostatic abscess. J Magn Reson Imaging 1999, 9:488–490.
Lee LK, Dinneen MD, Ahmad S: The urologist and the patient infected with human immunodeficiency virus or with acquired immunodeficiency syndrome. BJU Int 2001, 88:500–510.
Staiman VR, Lowe FC: Prostatic disease in HIV-infected patients. Infect Urol 1996, 9:42–47,60.
Nickel JC: The three As of chronic prostatitis therapy: antibiotics, alpha-blockers, and anti-inflammatories. What is the evidence? BJU Int 2004, 94:1230–1233. Excellent overview of the clinical evidence of the current treatments for chronic prostatitis.
Lowe FC, Fagelman E: Phytotherapy for chronic prostatitis. Curr Urol Rep 2000, 1:164–166.
Shoskes DA: Phytotherapy in chronic prostatitis. Urology 2002, 60:35–37.
Nickel JC, Forrest JB, Tomera K: Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo-controlled study. J Urol 2005, 173:1252–1255.
Nickel JC, Pontari M, Moon T, et al.: A randomized, placebo-controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003, 169:1401–1405.
Shoskes DA, Zeitlin SI, Shahed A, Rajfer J: Quercetin in men with category-III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999, 54:960–963.
Nickel JC, Downey J, Pontari MA, et al.: A randomized, placebo-controlled, multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category-IIIA chronic nonbacterial prostatitis). BJU Int 2004, 93:991–995.
Kaplan SA, Volpe MA, Te AE: A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome. J Urol 2004, 171:284–288.
Cheah PY, Liong ML, Yuen KH, et al.: Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo-controlled trial. J Urol 2003, 169:592–596.
Mehik A, Alas P, Nickel JC, et al.: Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled pilot study. Urology 2003, 62:425–429.
Nickel JC, Narayan P, McKay J, Doyle C: Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized, double-blind trial. J Urol 2004, 171:1594–1597.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Santillo, V.M., Lowe, F.C. The management of chronic prostatitis in men with HIV. Curr prostate rep 4, 93–99 (2006). https://doi.org/10.1007/s11918-006-0006-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11918-006-0006-z